IFIT5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.271600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.598400E-01
Normal-vs-Stage2
1.556150E-01
Normal-vs-Stage3
1.251370E-01
Normal-vs-Stage4
2.462400E-01
Stage1-vs-Stage2
7.607400E-01
Stage1-vs-Stage3
1.077840E-01
Stage1-vs-Stage4
4.647000E-01
Stage2-vs-Stage3
2.535200E-01
Stage2-vs-Stage4
7.323000E-01
Stage3-vs-Stage4
4.661200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.268820E-01
Normal-vs-AfricanAmerican
3.509400E-01
Normal-vs-Asian
3.005200E-01
Caucasian-vs-AfricanAmerican
7.309200E-01
Caucasian-vs-Asian
9.007400E-01
AfricanAmerican-vs-Asian
7.701200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.766780E-01
Normal-vs-Female
8.765800E-02
Male-vs-Female
7.131800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.288000E-01
Normal-vs-Age(41-60Yrs)
2.678600E-01
Normal-vs-Age(61-80Yrs)
1.117200E-01
Normal-vs-Age(81-100Yrs)
2.154000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.198000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.210200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.917190E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.076190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.223870E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.270210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.434200E-02
Normal-vs-Daily Drinker
9.279900E-02
Normal-vs-Weekly Drinker
3.067600E-01
Normal-vs-Occasional Drinker
1.492150E-01
Normal-vs-Social Drinker
2.411400E-01
Non Drinker-vs-Daily Drinker
3.706400E-01
Non Drinker-vs-Weekly Drinker
4.459800E-01
Non Drinker-vs-Occasional Drinker
3.056400E-01
Non Drinker-vs-Social Drinker
1.245030E-01
Daily Drinker-vs-Weekly Drinker
8.059200E-01
Daily Drinker-vs-Occasional Drinker
8.496400E-01
Daily Drinker-vs-Social Drinker
4.879000E-01
Weekly Drinker-vs-Occasional Drinker
9.301600E-01
Weekly Drinker-vs-Social Drinker
7.790000E-01
Occasional Drinker-vs-Social Drinker
6.402000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.330400E-01
Normal-vs-Grade 2
3.610400E-02
Normal-vs-Grade 3
2.100400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.841700E-02
Grade 1-vs-Grade 3
3.012200E-02
Grade 1-vs-Grade 4
1.330400E-01
Grade 2-vs-Grade 3
7.908600E-01
Grade 2-vs-Grade 4
3.610400E-02
Grade 3-vs-Grade 4
2.100400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.307800E-02
Normal-vs-NonDiabetic
1.350020E-01
Diabetic-vs-NonDiabetic
4.612800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.019570E-01
Normal-vs-NoPancreatitis
1.245420E-01
Pancreatitis-vs-NoPancreatitis
8.599000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.578000E-02
Normal-vs-N1
1.624600E-01
N0-vs-N1
3.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.305400E-01
Normal-vs-TP53-NonMutant
2.350600E-01
TP53-Mutant-vs-TP53-NonMutant
3.065000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
